Neuromodulation Devices Market USD 8.2 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.
Maryland Heights, MO, October 06, 2016 --(PR.com)-- According to a market research report Neuromodulation Devices Market, 2013-2020, published by iHealthcareAnalyst, Inc., the global neuromodulation devices market is estimated to reach USD 8.2 Billion in 2020, expanding at a CAGR of 14.3% from 2016 to 2020.
Visit the Neuromodulation Devices Market, 2013-2020 report at https://www.ihealthcareanalyst.com/report/neuromodulation-devices-market/
The global neuromodulation devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
Neuromodulation includes treatments that involve stimulation or administration of medications directly to the body’s nervous system for therapeutic purposes. The target cells for stimulation include nerves in the central and peripheral nervous system, the autonomic nervous system and the deep cell nuclei of the brain, resulting in modulation of their activity. It can be used to treat movement disorders, spasticity, epilepsy as well as pain syndromes.
The global neuromodulation devices market segmentation is based on technology (spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices). The global global neuromodulation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global neuromodulation devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Technology
1.1 Spinal Cord Stimulation Devices
1.2 Deep Brain Stimulation Devices
1.3 Sacral Nerve Stimulation Devices
1.4 Vagus Nerve Stimulation Devices
1.5 Gastric Electric Stimulation Devices
2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World
3. Company Profiles
3.1 Boston Scientific
3.2 Cyberonics
3.3 Medtronics
3.4 Nervo
3.5 Neurotics, Inc.
3.6 St. Jude Medical
3.7 Uroplasty
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Visit the Neuromodulation Devices Market, 2013-2020 report at https://www.ihealthcareanalyst.com/report/neuromodulation-devices-market/
The global neuromodulation devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
Neuromodulation includes treatments that involve stimulation or administration of medications directly to the body’s nervous system for therapeutic purposes. The target cells for stimulation include nerves in the central and peripheral nervous system, the autonomic nervous system and the deep cell nuclei of the brain, resulting in modulation of their activity. It can be used to treat movement disorders, spasticity, epilepsy as well as pain syndromes.
The global neuromodulation devices market segmentation is based on technology (spinal cord stimulation devices, deep brain stimulation devices, sacral nerve stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices). The global global neuromodulation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global neuromodulation devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Technology
1.1 Spinal Cord Stimulation Devices
1.2 Deep Brain Stimulation Devices
1.3 Sacral Nerve Stimulation Devices
1.4 Vagus Nerve Stimulation Devices
1.5 Gastric Electric Stimulation Devices
2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World
3. Company Profiles
3.1 Boston Scientific
3.2 Cyberonics
3.3 Medtronics
3.4 Nervo
3.5 Neurotics, Inc.
3.6 St. Jude Medical
3.7 Uroplasty
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories